A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Explore 11592 conditions in our directory, and growing.
Condition name for this article.

Severe aplastic anemia

Other Names: SAA, Severe aplastic anaemia, Severe AA, Aplastic anemia, severe.
Causes Symptoms Treatment Prognosis Lifestyle FAQ

At a Glance

Severe aplastic anemia is a rare and critical bone marrow failure disorder where the body stops producing enough new blood cells, resulting in debilitating fatigue, a high risk of life-threatening infections, and uncontrolled bleeding.
This rare condition affects approximately two people per million annually and typically appears in two distinct age groups: adolescents and young adults aged 15 to 25, and older adults over the age of 60.
It is an acute, life-threatening condition that requires urgent hospital care upon diagnosis but can often be successfully treated or managed as a chronic illness with long-term therapies.
While the condition is fatal if left untreated, modern treatments such as stem cell transplants and triple-drug immunosuppressive therapy have significantly improved the prognosis, allowing the majority of patients to achieve long-term survival or a complete cure.

See Your Ranked Personalized Treatments

A graphic depicting a sample medication report that registered members can run.
Impact in entire body.

How It Affects You

Severe aplastic anemia affects the entire body because it stems from a failure of the bone marrow to produce sufficient blood cells. This systemic deficiency leads to three primary physiological problems: anemia, neutropenia, and thrombocytopenia. The lack of red blood cells deprives tissues of oxygen, causing exhaustion and strain on the heart; the lack of white blood cells leaves the body without a defense system against bacteria and viruses; and the lack of platelets results in an inability to form clots, leading to spontaneous or prolonged bleeding.

.

Causes and Risk Factors

Underlying Biological Mechanisms
Severe aplastic anemia is primarily an autoimmune disease. In about 70% to 80% of cases, the body's own immune system—specifically T-cells—mistakenly attacks and destroys the hematopoietic stem cells in the bone marrow. These stem cells are responsible for producing all types of blood cells. When they are destroyed, the bone marrow becomes "aplastic" or empty, replaced largely by fat cells, and can no longer keep up with the body's need for fresh blood.

Causes and Risk Factors
For many patients, the cause is "idiopathic," meaning no specific trigger is ever identified. However, several known factors can trigger the condition:

  • Toxic Chemicals: Long-term exposure to toxic substances, particularly benzene (found in gasoline and used in industrial manufacturing) and certain pesticides, is a well-established cause.
  • Medications: Certain drugs, including specific antibiotics (like chloramphenicol) and medications for rheumatoid arthritis, have been linked to bone marrow failure.
  • Viral Infections: Infections such as hepatitis, Epstein-Barr virus (EBV), cytomegalovirus (CMV), and HIV can trigger the immune system to attack the bone marrow.
  • Radiation and Chemotherapy: Cancer treatments designed to kill rapidly dividing cells can damage bone marrow stem cells, though this is usually temporary; in rare cases, it leads to permanent aplasia.
  • Inherited Conditions: A minority of cases are not autoimmune but are caused by genetic disorders like Fanconi anemia or telomere biology disorders.

Prevention
Because most cases are idiopathic or autoimmune with no clear trigger, there is no known way to prevent severe aplastic anemia for the general population. Secondary prevention focuses on avoiding known marrow toxins, such as benzene and unnecessary exposure to radiation. Strict adherence to safety protocols in industrial workplaces handling solvents can reduce risk.

A graphic depicting a sample medication report that registered members can run.
.

Diagnosis, Signs, and Symptoms

Signs and Symptoms
Symptoms of severe aplastic anemia result directly from the shortage of the three main blood cell types (pancytopenia). They often appear suddenly and can be severe:

  • Red Blood Cell Deficiency (Anemia): Causes profound fatigue, pale skin, shortness of breath upon exertion, dizziness, and a rapid or irregular heart rate.
  • White Blood Cell Deficiency (Neutropenia): Causes frequent or prolonged infections, fevers, and flu-like symptoms that do not go away. Patients may develop severe infections from minor cuts.
  • Platelet Deficiency (Thrombocytopenia): Causes easy bruising, pinhead-sized red spots on the skin (petechiae), bleeding gums, frequent nosebleeds, and prolonged bleeding from minor scrapes.

Diagnostic Tests
Clinicians use specific tests to confirm the diagnosis and distinguish it from other conditions:

  • Complete Blood Count (CBC): This blood test shows low levels of all three blood cell types. In severe cases, neutrophils are extremely low.
  • Reticulocyte Count: This measures the number of young red blood cells; a low count confirms the marrow is not producing new cells.
  • Bone Marrow Biopsy and Aspiration: A sample is taken from the hip bone. In severe aplastic anemia, the sample shows "hypocellularity" (very few cells) and is mostly fat. This is the definitive test.
  • Molecular and Genetic Testing: These tests check for inherited bone marrow failure syndromes or paroxysmal nocturnal hemoglobinuria (PNH), which often co-occurs with aplastic anemia.

Differential Diagnosis
Doctors must rule out other conditions that cause low blood counts, such as Myelodysplastic Syndromes (MDS), acute leukemia, vitamin deficiencies (B12/folate), and PNH.

.

Treatment and Management

Medical Treatments
Treatment requires immediate medical attention and is tailored to the patient's age and donor availability.

  • Stem Cell Transplant (Bone Marrow Transplant): This is the only potential cure. It involves replacing the damaged bone marrow with healthy stem cells from a donor. It is the standard of care for younger, healthy patients who have a matched sibling donor.
  • Immunosuppressive Therapy (IST): For older patients or those without a donor, a triple-drug regimen is the standard treatment. This typically involves horse antithymocyte globulin (ATG), cyclosporine, and eltrombopag. This combination stops the immune system from attacking the marrow and stimulates stem cells to produce blood again.
  • Blood Transfusions: These are used to support the patient by keeping blood counts at safe levels while waiting for other treatments to work.

Management and Monitoring
Management involves strict monitoring of blood counts and organ function. Patients on immunosuppressants require preventative antibiotics and antifungals to avoid infection. Periodic bone marrow biopsies may be needed to check for disease progression or relapse.

When to See a Doctor
Patients with this condition are in a fragile state. Immediate medical care is required for:

  • Fever: A temperature of 100.4°F (38°C) or higher is a medical emergency in patients with low white blood cells and requires an immediate trip to the ER.
  • Uncontrolled Bleeding: Nosebleeds that won't stop, blood in stool or urine, or severe bruising should be evaluated immediately.
  • Signs of Infection: Cough, redness around a wound, or chills warrant urgent assessment.

A graphic depicting a sample medication report that registered members can run.
.

Severity and Prognosis

Severity Levels
Aplastic anemia is classified based on blood count levels. Severe Aplastic Anemia (SAA) is defined by bone marrow cellularity of less than 25% and extremely low neutrophils (less than 500 per microliter). Very Severe Aplastic Anemia (vSAA) is diagnosed when neutrophils drop below 200 per microliter. These forms are medical emergencies carrying a high risk of rapid mortality without intervention.

Prognosis and Disease Course
Historically, SAA had a very poor prognosis. However, with modern treatment, outcomes have changed dramatically:

  • Survival Rates: With current standard treatments (HSCT or Triple IST), 5-year survival rates are often between 80% and 90%, particularly for younger patients.
  • Response Timeline: Immunosuppressive therapy is not instant; it often takes 3 to 6 months to see a significant improvement in blood counts.
  • Relapse and Complications: Even after successful treatment, there is a risk of relapse. Additionally, about 15% of patients may eventually develop other bone marrow disorders, such as Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML). Long-term monitoring is essential to catch these changes early.

Factors Influencing Outcome
Younger age and the availability of a matched sibling donor are the strongest predictors of a cure. Older age and severe infections at the time of diagnosis can complicate recovery.

.

Impact on Daily Life

Daily Activities and Hygiene
Living with severe aplastic anemia requires significant lifestyle adjustments to prevent infection and bleeding. Patients often need to avoid crowds, wear masks, and wash hands frequently. Diet may need to be adjusted to avoid raw or undercooked foods that could harbor bacteria (neutropenic diet). Contact sports or activities with a risk of injury must be avoided to prevent dangerous internal bleeding.

Mental and Emotional Health
The sudden onset and severity of the illness, combined with the need for isolation, can lead to anxiety and depression. The waiting period for treatment to work is often stressful. Support groups for bone marrow failure can be vital resources.

Questions to Ask Your Healthcare Provider

  • Am I a candidate for a stem cell transplant, and do I have a match?
  • What are the side effects of the immunosuppressive drugs I will be taking?
  • How often do I need to come in for blood transfusions or check-ups?
  • What specific signs of infection should trigger a call to your office versus a trip to the emergency room?
  • Are there any clinical trials available for my condition?

A graphic depicting a sample medication report that registered members can run.
.

Common Questions and Answers

Q: Is severe aplastic anemia a form of cancer?
A: No, it is not cancer. However, it is a related bone marrow failure disorder, and the treatments (like chemotherapy for transplants) and risks (like developing leukemia later) can overlap with cancer care.

Q: Is this condition genetic or hereditary?
A: Most cases are acquired and not inherited. However, a small percentage of cases are due to inherited genetic syndromes like Fanconi anemia. Your doctor may run genetic tests to rule this out.

Q: Can I go back to work or school while being treated?
A: This depends on your blood counts and the nature of your work. Many patients need to take time off during the initial intensive treatment phase due to extreme fatigue and the risk of infection in public places.

Q: Will my blood counts ever return to normal?
A: With a successful stem cell transplant, blood counts usually return to completely normal levels. With immunosuppressive therapy, counts often improve enough to live a normal life, though they may remain slightly lower than average.

Q: Is it safe to exercise?
A: Light exercise like walking is generally encouraged to prevent muscle loss, but heavy lifting and high-impact activities should be avoided if your platelet count is low to prevent bleeding.

Content last updated on February 12, 2026. Always consult a qualified health professional before making any treatment decisions or taking any medications. Review our Terms of Service for full details.